Tci Wealth Advisors, Inc. Red Hill Biopharma Ltd. Transaction History

Tci Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 30, 2018	SELL	$4.96 - $6.84 $496 - $684	-100 Closed	0 $0
Q3 2017 Oct 24, 2017	SELL	$8.25 - $10.81 $1,650 - $2,162	-200 Reduced 66.67%	100 $1,000
Q2 2017 Aug 10, 2017	BUY	N/A	300	300 $3,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.